Blood concentrations and pharmacodynamic effects of betaxolol (SL 75212) a new beta-adrenoceptor antagonist after oral and intravenous administration

British Journal of Clinical Pharmacology
S J WarringtonP L Morselli

Abstract

1 In normal subjects, intravenous betaxolol given in doses which inhibited the tachycardia of exercise failed to affect the peak expiratory flow rate. 2 From 2 to 48 h after administration of 150 micrograms/kg in four normal subjects, there was no significant difference between the blood levels, whether given orally or intravenously. 3 At all times, heart rate and blood pressure, at rest and during exercise, were reduced equally after administration by both routes, but the area under the curve of exercise heart rate against time was significantly smaller (P < 0.05) after intravenous drug. 4 The absolute bioavailability of betaxolol was 89 +/- 5%.

References

Aug 1, 1978·Computers and Biomedical Research, an International Journal·C Gomeni, R Gomeni

❮ Previous
Next ❯

Citations

Apr 1, 1992·Journal of Clinical Pharmacology·R L WilliamsL B Hogan
Jan 1, 1991·European Journal of Clinical Pharmacology·B J LipworthD G McDevitt
Jan 1, 1986·European Journal of Clinical Pharmacology·G BianchettiJ P Thenot
Jan 1, 1983·European Journal of Clinical Pharmacology·R Palminteri, G Kaik
Jan 1, 1982·European Journal of Clinical Pharmacology·J T Salonen, R Palminteri
Jul 1, 1990·British Journal of Clinical Pharmacology·N A IrvineD G McDevitt
Nov 1, 1990·British Journal of Clinical Pharmacology·A J SinclairS J Warrington
Feb 1, 1991·British Journal of Clinical Pharmacology·B J LipworthD G McDevitt
Dec 15, 1985·American Journal of Ophthalmology·J G Feghali, P L Kaufman
Jun 1, 1983·British Journal of Clinical Pharmacology·C T DolleryG Cuisinaud
Dec 1, 1987·Journal of Clinical Pharmacy and Therapeutics·J V Okopski
Dec 14, 2011·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Alan GevinsAaron B Ilan
Dec 3, 2014·Psychiatry Research·Daniël KleinloogJoop van Gerven
Jun 12, 2021·Critical Care : the Official Journal of the Critical Care Forum·Josée BouchardUNKNOWN EXTRIP workgroup

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.